# PathMap Report Trace Context: #00000129
Hypothesis: COPD Dietary Idea:
According to PubMed literature, he following lunchtime meal plan provides nutrients needed for production and regulation of tryptophan and 3-IPA and may help reduce COPD flare-ups, while also providing mucosal support for clearance of debris from the lungs:

-2x slices sourdough bread, lightly spread with extra virgin olive oil, garlic, and ginger, with 2x slices of cooked turkey and spinach, with nutritional yeast and hi-maize corn starch mixed into the EVOO (for mucosal system support)
-a spinach-based salad with 1 Tbsp EVOO
-3 oz pomegranate juice mixed with 3 oz cherry juice
Author: Joshua Dungan (PathMap.org)
License: 'THE GLOBAL HUMANITARIAN PROPRIETARY LICENSE (VERSION 1.0.1)' https://pathmap.org/license.pdf
Full provenance JSON trace: https://pathmap.org/download.php/?id=129
==================================================

SYSTEM NOTE: The eight-digit ID numbers (e.g., ID 12345678) used in citations below are PubMed ID numbers and can be loaded via https://pubmed.ncbi.nlm.nih.gov/{ID}/ for verification.

==================================================

## Primary Synthesis & Clinical Bottom-Line
While the diet contains high-quality components associated with COPD and gut-lung axis health (tryptophan sources, prebiotics, and antioxidants), clinical data specifically linking this precise "lunchtime meal plan" to COPD exacerbation reduction or respiratory mucus clearance are currently insufficient. Evidence supports that dietary tryptophan, fiber (prebiotics), and antioxidants are beneficial, but therapeutic success depends on long-term systemic intake, and the gut-lung axis requires stable, diverse microbial ecosystems that are not guaranteed by single meals.

## Plausibility Verdicts
- Evaluation 1: The provided diet is rich in nutrients known to support the gut-lung axis (e.g., tryptophan, prebiotics, antioxidants); however, clinical evidence for this exact meal plan as a tool to prevent exacerbations is currently speculative and requires direct validation.

## Novel & Overlooked Insights
- Tryptophan-rich diets, when combined with gut microbiota-remodeling agents, have shown potential in reducing sterile lung ischemia-reperfusion injury and suppressing pulmonary inflammation.
- The "fibre gap" in COPD patients is a significant clinical target, as complex carbohydrates serve as substrates for gut microbiota to synthesize SCFAs and indole derivatives that protect the lung-gut axis.
- Intestinal permeability and endotoxemia are linked to COPD disease progression; restoring barrier integrity via nutritional support can modulate systemic inflammation.
- Carotenoid status in low-income COPD populations correlates with better health scores and lower frequency of severe exacerbations.
- IPA, an intestinal microbial metabolite, is specifically linked to the preservation of the posterior blood-retinal barrier and acts as a beneficial regulator in diabetic retinopathy and pulmonary models.

## Extracted Custom Discoveries
### Suggested Experiments
- Test the effect of the proposed meal plan on fecal IPA and SCFA concentration in COPD patients using a randomized crossover study design.
- Evaluate the impact of the described meal plan components on airway epithelial barrier integrity using a lung-gut-on-a-chip model.
- Quantify the change in inflammatory markers (TNF-a, IL-6) in COPD patients adhering to the proposed meal plan versus standard dietary guidance.

### Suggested Studies
- Longitudinal intervention trial measuring the gut microbiome diversity and respiratory function in COPD patients receiving the specified nutritional protocol over 12 months.
- Cross-sectional survey comparing the dietary antioxidant quality score (DAQS) and gut-derived indole levels in stable COPD patients versus those presenting with exacerbations.

### Swansons Literature Based Discovery Candidates
- Discovered Hypothesis (A to C): Microbiota-derived indole metabolites protect against emphysema-associated mitochondrial dysfunction by modulating mitophagy in alveolar type 2 (AT2) cells.
Literature A (Origin): ID 42579796 (Polymerized Z-AAT proteins in AT2 cells cause mitochondrial dysfunction and impaired autophagy/mitophagy).
Literature C (Target): ID 42584152 / 41741429 (Indole metabolites like IPA/ILA are proven to restore mitochondrial function and stimulate repair/regeneration via AhR and metabolic signaling).
The Intersecting Bridge B: Aryl hydrocarbon receptor (AhR) activation and restoration of mitochondrial fatty acid oxidation.
Biological Rationale: Polymerized proteins induce ER stress and mitochondrial failure in COPD-associated emphysema. AhR activation by indole metabolites, which is known to boost epithelial repair and barrier integrity, potentially counteracts these toxic accumulation-driven organelle defects.

### Contradictions Between Evidences
- There is a minor potential conflict between the protective hypothesis of some nutritional interventions (e.g., NUTRECOVER protocol) and the finding in ID 40481968 that three months of multi-nutrient supplementation was insufficient to show changes in microbiome composition, suggesting long-term compliance is the critical variable.

### Repurposed Solutions
- High-fiber dietary protocols, specifically using hi-maize or FOS/FBTB (Fu Brick Tea), are repositioned as microbiome-targeted strategies to reduce systemic inflammation and airway obstruction in COPD patients by increasing local luminal production of tryptophan-derived metabolites (IPA/IAA) which activate the AhR signaling pathway.

## Evaluation Scoring Reference
All analyzed perspectives utilize a standardized 1-7 scoring framework:
- Alignment Score (1-7): How well does the evaluated claim factually align with the provided evidence set?
  [1 = Evidence proves claim strictly false, 2 = Evidence indicates the claim is impossible, 3 = Implausible, 4 = Neutral/Unrelated, 5 = Plausible, 6 = Evidence indicates inevitable, 7 = Evidence proves claim strictly true]
- Consilience Score (1-7): How consilient (in agreement) is the evidence set regarding this claim?
  [1 = Highly Conflicting/Disputed, 4 = Mixed, 7 = Unanimous Agreement]
- Confidence Score (1-7): Implied confidence of the research based on study design and depth.
  [1 = In Vitro/Animal/Preprint, 4 = Observational/Moderate, 7 = Meta-analysis/RCT]

## Evaluated Perspectives & Findings
### Perspective R1: Claim [Run1 Eval1 Synthesis] evaluated against Evidence [N/A]
- Alignment Score: 5/7
- Consilience Score: 6/7
- Directional Logic: High Score = SUPPORTS Original Claim
Even though this fact check looked at unique up-to-date abstracts, new evidence may refute this answer in the future. Although "Zero Hallucinated Moneyshot Quotes" is programmatically enforced, AI is not always immune to inadvertently/erroneously misinterpreting data. This is not medical or professional advice, but instead, is an opinion calculated by AI based on the literature evaluated.

###[CLAIM EVALUATED]
The proposed meal plan (turkey, sourdough, EVOO, spinach, garlic, ginger, nutritional yeast, hi-maize corn starch, pomegranate juice, cherry juice) provides sufficient nutrients to regulate tryptophan and 3-IPA metabolism and reduce COPD exacerbations while supporting mucosal clearance.

### [CLINICAL BOTTOM-LINE / REWRITTEN CLAIM]
While the diet contains high-quality components associated with COPD and gut-lung axis health (tryptophan sources, prebiotics, and antioxidants), clinical data specifically linking this precise "lunchtime meal plan" to COPD exacerbation reduction or respiratory mucus clearance are currently insufficient. Evidence supports that dietary tryptophan, fiber (prebiotics), and antioxidants are beneficial, but therapeutic success depends on long-term systemic intake, and the gut-lung axis requires stable, diverse microbial ecosystems that are not guaranteed by single meals.

### [RISK VS REWARD & JUSTIFICATION]
The reward of this diet lies in the inclusion of tryptophan-rich foods (turkey) and fermentable substrates (spinach, hi-maize/resistant starch) that support gut-derived metabolites like indole-3-propionic acid (IPA), which demonstrate clear protective effects on epithelial barrier integrity and lung inflammation. However, the risk is a potential overestimation of efficacy, as clinical interventions often show that three months of nutrient supplementation is insufficient to modify the microbiome in established COPD patients. 

### [PATIENT APPLICATION: NOVEL & OVERLOOKED]
*   Tryptophan-rich diets, when combined with gut microbiota-remodeling agents, have shown potential in reducing sterile lung ischemia-reperfusion injury and suppressing pulmonary inflammation.
*   The "fibre gap" in COPD patients is a significant clinical target, as complex carbohydrates serve as substrates for gut microbiota to synthesize SCFAs and indole derivatives that protect the lung-gut axis.
*   Intestinal permeability and endotoxemia are linked to COPD disease progression; restoring barrier integrity via nutritional support can modulate systemic inflammation.
*   Carotenoid status in low-income COPD populations correlates with better health scores and lower frequency of severe exacerbations.
*   IPA, an intestinal microbial metabolite, is specifically linked to the preservation of the posterior blood-retinal barrier and acts as a beneficial regulator in diabetic retinopathy and pulmonary models.

### [EVIDENCE, METHODOLOGY & CITATIONS]
1. ID: 42352300 - Application: Tryptophan metabolites are key gut-derived mediators of lung health. - "Several colonic microbiota metabolites, including the short-chain fatty acids acetate, propionate, and butyrate, together with the tryptophan metabolites indole-3-acetate and indole-3-propionate, secondary bile acids, and the polyamines spermidine and putrescine, are transported to the lungs via the gut-lung axis."
2. ID: 41993317 - Application: Tryptophan-rich diets improve lung outcomes through IPA. - "A Trp-Rich diet attenuated sterile lung IR injury, coinciding with gut microbiota remodeling, increased systemic and pulmonary IPA, reduced inflammatory priming, and reprogrammed AM responses."
3. ID: 42451046 - Application: Dietary tryptophan supports barrier function. - "Dietary Try supplementation decreased circulating LPS levels, suppressed pulmonary TLR4/NF-κB signaling, upregulated AhR/interleukin-22 expression, attenuated oxidative stress and improved the capillary-epithelial barrier integrity in DSS-treated mice."
4. ID: 31737344 - Application: Fiber intake addresses the "fibre gap" in COPD. - "By addressing the 'fibre gap' in the diet of COPD patients, this targeted dietary intervention may reduce inflammation, both systemically and in the airways, and value-add to the paradigm shift in respiratory medicine, from reactive to personalised and participatory medicine."
5. ID: 40481968 - Application: Limitations of short-term dietary intervention. - "Three months of multi-nutrient supplementation is insufficient to show changes in microbiome composition."
6. ID: 42609350 - Application: Protective effects of specific nutraceuticals in COPD models. - "RES significantly alleviated airflow limitation and improved pulmonary function in COPD models (FEV0.3/FVC: SMD = 1.79, 95% CI [0.94, 2.63], P < 0.0001; lung compliance: SMD = 1.63, 95% CI [0.92, 2.33], P < 0.00001)."
7. ID: 41655865 - Application: IPA and AhR signaling in metabolic inflammation. - "Mechanistically, LE elevated both serum and intestinal IPA levels, increased expression of the aryl hydrocarbon receptor (AhR), and decreased phosphorylation of NF-κB."
8. ID: 42131229 - Application: Carbohydrate structure affects metabolite output. - "The monosaccharide composition, glycosidic linkage type, degree of branching, and degree of polymerization of complex carbohydrates can affect colonic fermentation kinetics and further alter the production ratio of SCFAs and tryptophan metabolites."
9. ID: 41741429 - Application: Microbial conversion of Trp to IPA. - "B. coccoides-derived indole-3-lactic acid (ILA), a tryptophan (Trp) metabolite, is converted into indole-3-propionic acid (IPA) by commensal bacteria such as P. russellii or C. sporogenes, stimulating IEC BHB synthesis."
10. ID: 41198173 - Application: IPA as a biomarker of intestinal and retinal health. - "T2D individuals with DR demonstrated elevated serum markers of endotoxemia and intestinal barrier disruption while showing reduced levels of the beneficial metabolite IPA and elevated levels of the toxic metabolite indole sulfate."
11. ID: 42099620 - Application: Tryptophan derivatives and immune differentiation. - "Microbial metabolites, particularly short-chain fatty acids (acetate, propionate, butyrate) and tryptophan derivatives (indole-3-lactic acid, indole-3-propionic acid), serve as key molecular mediators that regulate regulatory T cells differentiation, reinforce mucosal barriers, and modulate distal airway inflammation."
12. ID: 40751356 - Application: Probiotic modulation of tryptophan metabolism. - "B. breve M-16V supplementation was found to alleviate CMA symptoms, reverse Th2-biased immune response, and enhance intestinal barrier function."
13. ID: 42551547 - Application: Complexity of tryptophan effects in cancer and immunity. - "Importantly, Trp metabolites may exert either tumor-promoting or tumor-suppressive effects depending on microbial composition, metabolite concentration, receptor usage, immune contexture, tumor type, and therapeutic setting."
14. ID: 41758665 - Application: Dietary tryptophan dependency for lung injury protection. - "Murine dietary interventions demonstrated that high tryptophan intake alleviated ALI severity, whereas deficiency exacerbated injury, with protection being gut microbiota dependent."
15. ID: 42345645 - Application: Physiological monitoring via ultrasound. - "Pre-treatment VDI differed significantly between oxygen saturation groups, with the highest values in the most hypoxemic patients (p = 0.028)."
16. ID: 42426728 - Application: Swallowing dysfunction as a clinical parameter in COPD. - "Swallowing-related parameters assessed using clinical screening tools were associated with symptom severity (mMRC and CAT) and weight loss in patients with COPD."
17. ID: 42387971 - Application: Muscle oxygenation recovery in COPD. - "In COPD patients, the greater the difference in oxygen saturation (SpO2) levels before and after 6MWT, and the lower the haemoglobin level, the longer the T½ recovery time (p < 0.05)."
18. ID: 42345645 - Application: VDI response to treatment. - "VDI decreased significantly after treatment in all groups (p < 0.001 for all), with the greatest reduction in the 

## Logical Systems Map (Logical Gates)
- "Tryptophan" -> "Gut Microbiota"
- "Gut Microbiota" -> "Indolepropionic Acid"
- "IPA" -> "Lung"
- "Indolepropionic Acid" -> "Receptors, Aryl Hydrocarbon"
- "Receptors, Aryl Hydrocarbon" -> "Pulmonary inflammation"

## Verified Verbatim Quotes
- "Several colonic microbiota metabolites, including the short-chain fatty acids acetate, propionate, and butyrate, together with the tryptophan metabolites indole-3-acetate and indole-3-propionate, secondary bile acids, and the polyamines spermidine and putrescine, are transported to the lungs via the gut-lung axis."
- "A Trp-Rich diet attenuated sterile lung IR injury, coinciding with gut microbiota remodeling, increased systemic and pulmonary IPA, reduced inflammatory priming, and reprogrammed AM responses."
- "Dietary Try supplementation decreased circulating LPS levels, suppressed pulmonary TLR4/NF-κB signaling, upregulated AhR/interleukin-22 expression, attenuated oxidative stress and improved the capillary-epithelial barrier integrity in DSS-treated mice."
- "By addressing the 'fibre gap' in the diet of COPD patients, this targeted dietary intervention may reduce inflammation, both systemically and in the airways, and value-add to the paradigm shift in respiratory medicine, from reactive to personalised and participatory medicine."
- "Three months of multi-nutrient supplementation is insufficient to show changes in microbiome composition."
- "RES significantly alleviated airflow limitation and improved pulmonary function in COPD models (FEV0.3/FVC: SMD = 1.79, 95% CI [0.94, 2.63], P < 0.0001; lung compliance: SMD = 1.63, 95% CI [0.92, 2.33], P < 0.00001)."
- "Mechanistically, LE elevated both serum and intestinal IPA levels, increased expression of the aryl hydrocarbon receptor (AhR), and decreased phosphorylation of NF-κB."
- "The monosaccharide composition, glycosidic linkage type, degree of branching, and degree of polymerization of complex carbohydrates can affect colonic fermentation kinetics and further alter the production ratio of SCFAs and tryptophan metabolites."
- "B. coccoides-derived indole-3-lactic acid (ILA), a tryptophan (Trp) metabolite, is converted into indole-3-propionic acid (IPA) by commensal bacteria such as P. russellii or C. sporogenes, stimulating IEC BHB synthesis."
- "T2D individuals with DR demonstrated elevated serum markers of endotoxemia and intestinal barrier disruption while showing reduced levels of the beneficial metabolite IPA and elevated levels of the toxic metabolite indole sulfate."
- "Microbial metabolites, particularly short-chain fatty acids (acetate, propionate, butyrate) and tryptophan derivatives (indole-3-lactic acid, indole-3-propionic acid), serve as key molecular mediators that regulate regulatory T cells differentiation, reinforce mucosal barriers, and modulate distal airway inflammation."
- "B. breve M-16V supplementation was found to alleviate CMA symptoms, reverse Th2-biased immune response, and enhance intestinal barrier function."
- "Importantly, Trp metabolites may exert either tumor-promoting or tumor-suppressive effects depending on microbial composition, metabolite concentration, receptor usage, immune contexture, tumor type, and therapeutic setting."
- "Murine dietary interventions demonstrated that high tryptophan intake alleviated ALI severity, whereas deficiency exacerbated injury, with protection being gut microbiota dependent."
- "Pre-treatment VDI differed significantly between oxygen saturation groups, with the highest values in the most hypoxemic patients (p = 0.028)."
- "Swallowing-related parameters assessed using clinical screening tools were associated with symptom severity (mMRC and CAT) and weight loss in patients with COPD."
- "In COPD patients, the greater the difference in oxygen saturation (SpO2) levels before and after 6MWT, and the lower the haemoglobin level, the longer the T½ recovery time (p < 0.05)."
- "VDI decreased significantly after treatment in all groups (p < 0.001 for all), with the greatest reduction in the <80% group."
- "Quercetin inhibits oxidative stress by scavenging reactive oxidant species and promoting expression of antioxidant enzymes."
- "However, their effectiveness is often limited by physiological and biopharmaceutical barriers, such as mucociliary clearance, enzymatic degradation, and nonspecific deposition, which reduce drug retention and bioavailability."
- "Clinical studies have drawn associations between Prevotella abundance and lung homeostasis, indicating potential relationships between Prevotella and lung inflammation, infection defense, and lung function."
- "Preoperative inflammatory markers were significantly higher in patients with complications (NLR: 3.55 ± 1.07 vs. 1.79 ± 0.54, PLR: 156 ± 47 vs. 120 ± 36, SII: 825 ± 248 vs. 548 ± 164; all p < 0.001)."
- "The Roth score and the DSS show high sensitivity in determining discharge decisions for patients with ECOPD presenting at the ED, thus offering a swift and pragmatic solution for discharge decisions."
- "Cd (II) deposits in the midbrain, causing the accumulation of inflammatory lipids, which promote neuronal destruction."
- "These findings support a shared epithelial-immune and cytokine-regulatory genetic architecture across major chronic lung diseases and nominate biologically coherent candidate genes and pathways for future functional and translational studies."
- "Docking to tryptophan-2,3-dioxygenase (TDO2), indoleamine-2,3-dioxygenase-1 (IDO1) and 2-amino-3-carboxymuconic acid-6-semialdehyde decarboxylase was seen with most of the AlzD drugs."
- "No eligible study directly tested sheep yogurt or a defined sheep yogurt preparation in ALD-relevant experimental or clinical settings."
- "Overall, FBTB prevents obesity may be through modulating the gut microbiota-tryptophan-IL-22 axis to reduce intestinal lipid accumulation."
- "GP96 overexpression inhibits ERS-induced apoptosis, oxidative stress and inflammation in nicotineinduced in vitro COPD model through potentiating ERK activation."
- "Mechanistic research indicates NF-kB, MAPK, Nrf2, and cytokine signaling pathways as typical therapeutic targets."
- "Current evidence supports respiratory relevance of several SVOC classes but is insufficient to establish SVOCs as causal drivers of COPD progression."
- "XYS treatment significantly ameliorated depressive-like behaviors and restored functional connectivity within emotion-regulation brain networks."
- "Mechanistically, F-53B compromised intestinal barrier integrity, as evidenced by reduced occludin expression and disrupted ZO-1 continuity, accompanied by elevated circulating lipopolysaccharide (LPS) and a systemic pro-inflammatory cytokine shift."
- "The gut-lung axis provides a conceptual and mechanistic framework through which intestinal microbial alterations influence pulmonary immunity."
- "The tryptophan metabolite IAA alleviates OF fibrosis via AHR signaling, suggesting a potential protective role in treating TED."
- "Multivariable logistic regression identified age, male sex, urea, albumin, C-reactive protein (CRP), and Charlson Comorbidity Index as independent predictors of in-hospital mortality."
- "The concept of the interactome redefines disease outcome as the product of a dynamic and reciprocal dialogue among host immune status, gut microbiota structure and function, and pathogen virulence expression."
- "A higher CONUT score at admission is an independent risk factor for increased 3-year all-cause mortality in elderly hospitalized patients with AECOPD."
- "Lower ALI and higher CONUT scores were significantly associated with a higher prevalence of AF in COPD patients."
- "Several colonic microbiota metabolites, including the short-chain fatty acids acetate, propionate, and butyrate, together with the tryptophan metabolites indole-3-acetate and indole-3-propionate, secondary bile acids, and the polyamines spermidine and putrescine, are transported to the lungs via the gut-lung axis."
- "A Trp-Rich diet attenuated sterile lung IR injury, coinciding with gut microbiota remodeling, increased systemic and pulmonary IPA, reduced inflammatory priming, and reprogrammed AM responses."
- "Dietary Try supplementation decreased circulating LPS levels, suppressed pulmonary TLR4/NF-κB signaling, upregulated AhR/interleukin-22 expression, attenuated oxidative stress and improved the capillary-epithelial barrier integrity in DSS-treated mice."
- "By addressing the 'fibre gap' in the diet of COPD patients, this targeted dietary intervention may reduce inflammation, both systemically and in the airways, and value-add to the paradigm shift in respiratory medicine, from reactive to personalised and participatory medicine."
- "Three months of multi-nutrient supplementation is insufficient to show changes in microbiome composition."
- "RES significantly alleviated airflow limitation and improved pulmonary function in COPD models (FEV0.3/FVC: SMD = 1.79, 95% CI [0.94, 2.63], P < 0.0001; lung compliance: SMD = 1.63, 95% CI [0.92, 2.33], P < 0.00001)."
- "Mechanistically, LE elevated both serum and intestinal IPA levels, increased expression of the aryl hydrocarbon receptor (AhR), and decreased phosphorylation of NF-κB."
- "The monosaccharide composition, glycosidic linkage type, degree of branching, and degree of polymerization of complex carbohydrates can affect colonic fermentation kinetics and further alter the production ratio of SCFAs and tryptophan metabolites."
- "B. coccoides-derived indole-3-lactic acid (ILA), a tryptophan (Trp) metabolite, is converted into indole-3-propionic acid (IPA) by commensal bacteria such as P. russellii or C. sporogenes, stimulating IEC BHB synthesis."
- "T2D individuals with DR demonstrated elevated serum markers of endotoxemia and intestinal barrier disruption while showing reduced levels of the beneficial metabolite IPA and elevated levels of the toxic metabolite indole sulfate."
- "Microbial metabolites, particularly short-chain fatty acids (acetate, propionate, butyrate) and tryptophan derivatives (indole-3-lactic acid, indole-3-propionic acid), serve as key molecular mediators that regulate regulatory T cells differentiation, reinforce mucosal barriers, and modulate distal airway inflammation."
- "B. breve M-16V supplementation was found to alleviate CMA symptoms, reverse Th2-biased immune response, and enhance intestinal barrier function."
- "Importantly, Trp metabolites may exert either tumor-promoting or tumor-suppressive effects depending on microbial composition, metabolite concentration, receptor usage, immune contexture, tumor type, and therapeutic setting."
- "Murine dietary interventions demonstrated that high tryptophan intake alleviated ALI severity, whereas deficiency exacerbated injury, with protection being gut microbiota dependent."
- "Pre-treatment VDI differed significantly between oxygen saturation groups, with the highest values in the most hypoxemic patients (p = 0.028)."
- "Swallowing-related parameters assessed using clinical screening tools were associated with symptom severity (mMRC and CAT) and weight loss in patients with COPD."
- "In COPD patients, the greater the difference in oxygen saturation (SpO2) levels before and after 6MWT, and the lower the haemoglobin level, the longer the T½ recovery time (p < 0.05)."
- "VDI decreased significantly after treatment in all groups (p < 0.001 for all), with the greatest reduction in the <80% group."
- "Quercetin inhibits oxidative stress by scavenging reactive oxidant species and promoting expression of antioxidant enzymes."
- "However, their effectiveness is often limited by physiological and biopharmaceutical barriers, such as mucociliary clearance, enzymatic degradation, and nonspecific deposition, which reduce drug retention and bioavailability."
- "Clinical studies have drawn associations between Prevotella abundance and lung homeostasis, indicating potential relationships between Prevotella and lung inflammation, infection defense, and lung function."
- "Preoperative inflammatory markers were significantly higher in patients with complications (NLR: 3.55 ± 1.07 vs. 1.79 ± 0.54, PLR: 156 ± 47 vs. 120 ± 36, SII: 825 ± 248 vs. 548 ± 164; all p < 0.001)."
- "The Roth score and the DSS show high sensitivity in determining discharge decisions for patients with ECOPD presenting at the ED, thus offering a swift and pragmatic solution for discharge decisions."
- "Cd (II) deposits in the midbrain, causing the accumulation of inflammatory lipids, which promote neuronal destruction."
- "These findings support a shared epithelial-immune and cytokine-regulatory genetic architecture across major chronic lung diseases and nominate biologically coherent candidate genes and pathways for future functional and translational studies."
- "Docking to tryptophan-2,3-dioxygenase (TDO2), indoleamine-2,3-dioxygenase-1 (IDO1) and 2-amino-3-carboxymuconic acid-6-semialdehyde decarboxylase was seen with most of the AlzD drugs."
- "No eligible study directly tested sheep yogurt or a defined sheep yogurt preparation in ALD-relevant experimental or clinical settings."
- "Overall, FBTB prevents obesity may be through modulating the gut microbiota-tryptophan-IL-22 axis to reduce intestinal lipid accumulation."
- "GP96 overexpression inhibits ERS-induced apoptosis, oxidative stress and inflammation in nicotineinduced in vitro COPD model through potentiating ERK activation."
- "Mechanistic research indicates NF-kB, MAPK, Nrf2, and cytokine signaling pathways as typical therapeutic targets."
- "Current evidence supports respiratory relevance of several SVOC classes but is insufficient to establish SVOCs as causal drivers of COPD progression."
- "XYS treatment significantly ameliorated depressive-like behaviors and restored functional connectivity within emotion-regulation brain networks."
- "Mechanistically, F-53B compromised intestinal barrier integrity, as evidenced by reduced occludin expression and disrupted ZO-1 continuity, accompanied by elevated circulating lipopolysaccharide (LPS) and a systemic pro-inflammatory cytokine shift."
- "The gut-lung axis provides a conceptual and mechanistic framework through which intestinal microbial alterations influence pulmonary immunity."
- "The tryptophan metabolite IAA alleviates OF fibrosis via AHR signaling, suggesting a potential protective role in treating TED."
- "Multivariable logistic regression identified age, male sex, urea, albumin, C-reactive protein (CRP), and Charlson Comorbidity Index as independent predictors of in-hospital mortality."
- "The concept of the interactome redefines disease outcome as the product of a dynamic and reciprocal dialogue among host immune status, gut microbiota structure and function, and pathogen virulence expression."
- "A higher CONUT score at admission is an independent risk factor for increased 3-year all-cause mortality in elderly hospitalized patients with AECOPD."
- "Lower ALI and higher CONUT scores were significantly associated with a higher prevalence of AF in COPD patients."
- "UPF-10 treatment significantly alleviated lung injury, and fibrosis, and reduced lung and thymus indices."
- "MXSG significantly alleviated pulmonary inflammation, reduced bronchoalveolar lavage eosinophils and improved histopathology."
- "Dyspnea severity was significantly higher in the PRISm phenotype."
- "After feature selection via Least Absolute Shrinkage and Selection Operator (LASSO) regression, the H2O AutoML platform was employed to train and compare models across 6 algorithm families."
- "Short-term carbocisteine administration significantly reduced airway mucus obstruction, potentially through decreased concentrations of Muc5ac and Muc5b."
- "Exposure to environmental allergens, pollutants, and respiratory pathogens disrupts epithelial tight junctions and triggers the rapid release of key alarmins, including TSLP, IL-33, and IL-25."
- "The airway epithelium expresses a diverse array of K+ channels that regulate key functions such as transepithelial ion transport, ciliary beating, and mucus secretion."
- "In this context, non-invasive mechanical ventilation (NIV) emerges as an intervention with high biological plausibility as an adjunct during physical training."
- "Non-invasive ventilation (primarily CPAP and BiPAP) has a well-established role in acute cardiogenic pulmonary edema and COPD exacerbations, reducing intubation rates and mortality."
- "Serum queuine concentrations increased stepwise from healthy controls to COPD, were higher in CH than CL, and were highest in COPD complicated by lung cancer."
- "We discuss the potential role of persistent SARS-CoV-2 viral reservoirs in "sanctuary sites" like the gastrointestinal tract and the reactivation of latent viruses such as Epstein-Barr virus (EBV)."